Literature DB >> 32493778

Optimization and Evaluation of a Multiplex Quantitative PCR Assay for Detection of Nucleic Acids in Human Blood Samples from Patients with Spotted Fever Rickettsiosis, Typhus Rickettsiosis, Scrub Typhus, Monocytic Ehrlichiosis, and Granulocytic Anaplasmosis.

Megan E Reller1, J Stephen Dumler2.   

Abstract

Spotted fever group rickettsioses (SFGR), typhus group rickettsioses (TGR), scrub typhus (caused by Orientia tsutsugamushi), ehrlichiosis, and anaplasmosis often present as undifferentiated fever but are not treated by agents (penicillins and cephalosporins) typically used for acute febrile illness. Inability to diagnose these infections when the patient is acutely ill leads to excess morbidity and mortality. Failure to confirm these infections retrospectively if a convalescent blood sample is not obtained also impairs epidemiologic and clinical research. We designed a multiplex real-time quantitative PCR (qPCR) assay to detect SFGR, TGR, O. tsutsugamushi, and infections caused by Anaplasma phagocytophilum and Ehrlichia chaffeensis with the ompA, 17-kDa surface antigen gene, tsa56, msp2 (p44), and vlpt gene targets, respectively. Analytical sensitivity was ≥2 copies/μl (linear range, 2 to 2 × 105) and specificity was 100%. Clinical sensitivities for SFGR, TGR, and O. tsutsugamushi were 25%, 20%, and 27%, respectively, and specificities were 98%, 99%, and 100%, respectively. Clinical sensitivities for A. phagocytophilum and E. chaffeensis were 93% and 84%, respectively, and specificities were 99% and 98%, respectively. This multiplex qPCR assay could support early clinical diagnosis and treatment, confirm acute infections in the absence of a convalescent-phase serum sample, and provide the high-throughput testing required to support large clinical and epidemiologic studies. Because replication of SFGR and TGR in endothelial cells results in very low bacteremia, optimal sensitivity of qPCR for these rickettsioses will require use of larger volumes of input DNA, which could be achieved by improved extraction of DNA from blood and/or extraction of DNA from a larger initial volume of blood.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Anaplasma phagocytophilumzzm321990; Ehrlichia chaffeensiszzm321990; Orientia spp.; Rickettsia spp.; Rickettsialeszzm321990; anaplasmosis; diagnostics; ehrlichioses; etiology of fever studies; scrub typhus; spotted fever and typhus group rickettsioses; ticks

Year:  2020        PMID: 32493778      PMCID: PMC7448621          DOI: 10.1128/JCM.01802-19

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  45 in total

1.  Use of Peptide-Based Enzyme-Linked Immunosorbent Assay followed by Immunofluorescence Assay To Document Ehrlichia chaffeensis as a Cause of Febrile Illness in Nicaragua.

Authors:  Ijeuru Chikeka; Armando J Matute; J Stephen Dumler; Christopher W Woods; Orlando Mayorga; Megan E Reller
Journal:  J Clin Microbiol       Date:  2016-04-06       Impact factor: 5.948

2.  Multiplex 5' nuclease quantitative real-time PCR for clinical diagnosis of malaria and species-level identification and epidemiologic evaluation of malaria-causing parasites, including Plasmodium knowlesi.

Authors:  Megan E Reller; Wan Hsin Chen; Justin Dalton; Marguerite A Lichay; J Stephen Dumler
Journal:  J Clin Microbiol       Date:  2013-06-26       Impact factor: 5.948

Review 3.  Neglected bacterial zoonoses.

Authors:  I Chikeka; J S Dumler
Journal:  Clin Microbiol Infect       Date:  2015-05-08       Impact factor: 8.067

Review 4.  Strategies for detecting rickettsiae and diagnosing rickettsial diseases.

Authors:  Alison Luce-Fedrow; Kristin Mullins; Alex P Kostik; Heidi K St John; Ju Jiang; Allen L Richards
Journal:  Future Microbiol       Date:  2015       Impact factor: 3.165

5.  Comparison of multiplex PCR hybridization-based and singleplex real-time PCR-based assays for detection of low prevalence pathogens in spiked samples.

Authors:  Donna Hockman; Ming Dong; Hong Zheng; Sanjai Kumar; Matthew D Huff; Elena Grigorenko; Maureen Beanan; Robert Duncan
Journal:  J Microbiol Methods       Date:  2016-11-09       Impact factor: 2.363

6.  Host- and microbe-related risk factors for and pathophysiology of fatal Rickettsia conorii infection in Portuguese patients.

Authors:  Rita de Sousa; Ana França; Sónia Dória Nòbrega; Adelaide Belo; Mario Amaro; Tiago Abreu; José Poças; Paula Proença; José Vaz; Jorge Torgal; Fátima Bacellar; Nahed Ismail; David H Walker
Journal:  J Infect Dis       Date:  2008-08-15       Impact factor: 5.226

Review 7.  A Systematic Review of Mortality from Untreated Scrub Typhus (Orientia tsutsugamushi).

Authors:  Andrew J Taylor; Daniel H Paris; Paul N Newton
Journal:  PLoS Negl Trop Dis       Date:  2015-08-14

Review 8.  A review of the global epidemiology of scrub typhus.

Authors:  Guang Xu; David H Walker; Daniel Jupiter; Peter C Melby; Christine M Arcari
Journal:  PLoS Negl Trop Dis       Date:  2017-11-03

9.  Defining an Optimal Cut-Point Value in ROC Analysis: An Alternative Approach.

Authors:  Ilker Unal
Journal:  Comput Math Methods Med       Date:  2017-05-31       Impact factor: 2.238

10.  Development and Clinical Validation of a Multiplex Real-Time Quantitative PCR Assay for Human Infection by Anaplasma phagocytophilum and Ehrlichia chaffeensis.

Authors:  Megan E Reller; J Stephen Dumler
Journal:  Trop Med Infect Dis       Date:  2018-01-29
View more
  2 in total

1.  Rickettsioses and Q Fever in Tanzania: Estimating the Burden of Pervasive and Neglected Causes of Severe Febrile Illness in Sub-Saharan Africa.

Authors:  Paul W Blair; Mohammed Lamorde; J Stephen Dumler
Journal:  Am J Trop Med Hyg       Date:  2021-12-20       Impact factor: 2.345

2.  Anaplasma phagocytophilum Ankyrin A Protein (AnkA) Enters the Nucleus Using an Importin-β-, RanGTP-Dependent Mechanism.

Authors:  Yuri Kim; Jianyang Wang; Emily G Clemens; Dennis J Grab; J Stephen Dumler
Journal:  Front Cell Infect Microbiol       Date:  2022-05-26       Impact factor: 6.073

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.